The potential contribution of stress systems to the transition to chronic whiplash-associated disorders

Spine

Volumn 36, Issue , 2011, Pages S226-S232

  McLean, Samuel A ^a  

^a UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

Author keywords

Motor vehicle collision; Musculoskeletal pain; Stress; WAD

Indexed keywords

ADRENERGIC RECEPTOR; CATECHOLAMINE;

ANIMAL; CHRONIC PAIN; DISEASE COURSE; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGICAL STRESS; PHYSIOLOGY; REVIEW; WHIPLASH INJURY;

ANIMALS; CATECHOLAMINES; CHRONIC PAIN; DISEASE PROGRESSION; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY-ADRENAL SYSTEM; RECEPTORS, ADRENERGIC; STRESS, PHYSIOLOGICAL; WHIPLASH INJURIES;

EID: 84859415750     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e3182387fb4     Document Type: Article

References (92)

1. Cassidy JD, Carroll LJ, Cote P, et al. Effect of eliminating compensation for pain and suffering on the outcome of insurance claims for whiplash injury. N Engl J Med 2000;342:1179-86.
2. Obelieniene D, Bovim G, Schrader H, et al. Headache after whiplash: a historical cohort study outside the medico-legal context. Cephalalgia 1998;18:559-64.
3. Partheni M, Constantoyannis C, Ferrari R, et al. A prospective cohort study of the outcome of acute whiplash injury in Greece. Clin Exp Rheumatol 2000;18:67-70.
4. Meyer S, Hugemann RE, Weber M. Zur Belastung der HWS dutch Auffahrkollisionen. Verkehrsunfall und Fahrzeugtechnik 1994;32:187-99.
5. Castro WH. Correlation between exposure to biomechanical stress and Whiplash Associated Disorders (WAD). Pain Res Manag 2003;8:76-8.
6. Castro WH, Meyer SJ, Becke ME, et al. No stress-no whiplash? Prevalence of "whiplash" symptoms following exposure to a placebo rear-end collision. Int J Legal Med 2001;114:316-22.
7. Vlaeyen JW, Linton SJ. Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art. Pain 2000;85:317-32.
8. Nederhand MJ, Hermens HJ, IJzerman MJ, et al. Chronic neck pain disability due to an acute whiplash injury. Pain 2003;102:63-71.
9. Sterling M, Jull G, Vicenzino B, et al. Characterization of acute whiplash-associated disorders. Spine 2004;29:182-8.
10. Sterling M, Jull G, Vicenzino B, et al. Sensory hypersensitivity occurs soon after whiplash injury and is associated with poor recovery. Pain 2003;104:507-19.
11. Curatolo M, Petersen-Felix S, Arendt-Nielsen L, et al. Central hypersensitivity in chronic pain after whiplash injury. Clin J Pain 2001;17:306-15.
12. Banic B, Petersen-Felix S, Andersen OK, et al. Evidence for spinal cord hypersensitivity in chronic pain after whiplash injury and in fibromyalgia. Pain 2004;107:7-15.
13. Kvetnansky R, Sabban EL, Palkovits M. Catecholaminergic systems in stress: structural and molecular genetic approaches. Physiol Rev 2009;89:535-606.
14. Goldstein DS. Catecholamines and stress. Endocr Regul 2003;37:69-80.
15. Chrousos GP. Stressors, stress, and neuroendocrine integration of the adaptive response. The 1997 Hans Selye Memorial Lecture. Ann N Y Acad Sci 1998;851:311-35.
16. Mangano DT, Layug EL, Wallace A, et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 1996;335:1713-20.
17. Grassi G. Sympathetic overdrive and cardiovascular risk in the metabolic syndrome. Hypertens Res 2006;29:839-47.
18. McLean SA, Clauw DJ, Abelson JL, et al. The development of persistent pain and psychological morbidity after motor vehicle collision: integrating the potential role of stress response systems into a biopsychosocial model. Psychosom Med 2005;67:783-90.
19. Imbe H, Iwai-Liao Y, Senba E. Stress-induced hyperalgesia: animal models and putative mechanisms. Front Biosci 2006;11:2179-92.
20. Vidal C, Jacob J. Hyperalgesia induced by non-noxious stress in the rat. Neurosci Lett 1982;32:75-80.
21. Vidal C, Jacob JJ. Stress hyperalgesia in rats: an experimental animal model of anxiogenic hyperalgesia in human. Life Sci 1982;31:1241-4.
22. Jorum E. Analgesia or hyperalgesia following stress correlates with emotional behavior in rats. Pain 1988;32:341-8.
23. Jorum E. Noradrenergic mechanisms in mediation of stress-induced hyperalgesia in rats. Pain 1988;32:349-55.
24. Satoh M, Kuraishi Y, Kawamura M. Effects of intrathecal antibodies to substance P, calcitonin gene-related peptide and galanin on repeated cold stress-induced hyperalgesia: comparison with carrageenan- induced hyperalgesia. Pain 1992;49:273-8.
25. Gamaro GD, Xavier MH, Denardin JD, et al. The effects of acute and repeated restraint stress on the nociceptive response in rats. Physiol Behav 1998;63:693-7.
26. da Silva Torres IL, Bonan CD, Crema L, et al. Effect of drugs active at adenosine receptors upon chronic stress-induced hyperalgesia in rats. Eur J Pharmacol 2003;481:197-201.
27. da Silva Torres IL, Cucco SN, Bassani M, et al. Long-lasting delayed hyperalgesia after chronic restraint stress in rats-effect of morphine administration. Neurosci Res 2003;45:277-83.
28. Imbe H, Murakami S, Okamoto K, et al. The effects of acute and chronic restraint stress on activation of ERK in the rostral ventromedial medulla and locus coeruleus. Pain 2004;112:361-71.
29. Quintero L, Moreno M, Avila C, et al. Long-lasting delayed hyperalgesia after subchronic swim stress. Pharmacol Biochem Behav 2000;67:449-58.
30. Diamond DM, Campbell AM, Park CR, et al. The temporal dynamics model of emotional memory processing: a synthesis on the neurobiological basis of stress-induced amnesia, flashbulb and traumatic memories, and the Yerkes-Dodson law. Neural Plast; 2007:60803.
31. Joels M, Pu Z, Wiegert O, et al. Learning under stress: how does it work? Trends Cogn Sci 2006;10:152-8.
32. Ivy AC, Gorrzl FR, Burmill DY. The analgesic effect of intracarotid and intravenous infection of epinephrine in dogs and of subcutaneous injection in man. Quart Bull Northw Univ med Sch 1944;18:298-306.
33. Leimdorfer A, Metzner WR. Analgesia and anesthesia induced by epinephrine. Am J Physiol 1949;157:116-21.
34. Nackley AG, Tan KS, Fecho K, et al. Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both beta(2)- and beta(3)-adrenergic receptors. Pain 2006;128:199-208.
35. Khasar SG, Green PG, Miao FJ, et al. Vagal modulation of nociception is mediated by adrenomedullary epinephrine in the rat. Eur J Neurosc i 2003;17:909-15.
36. Khasar SG, McCarter G, Levine JD. Epinephrine produces a betaadrenergic receptor-mediated mechanical hyperalgesia and in vitro sensitization of rat nociceptors. J Neurophysiol 1999;81:1104-12.
37. Levine JD, Dardick SJ, Roizen MF, et al. Contribution of sensory afferents and sympathetic efferents to joint injury in experimental arthritis. J Neurosci 1986;6:3423-9.
38. Coderre TJ, Basbaum AI, Dallman MF, et al. Epinephrine exacerbates arthritis by an action at presynaptic B2-adrenoceptors. Neuroscience 1990;34:521-3.
39. Diatchenko L, Anderson AD, Slade GD, et al. Three major haplotypes of the β 2 adrenergic receptor define psychological profile, blood pressure, and the risk for development of a common musculoskeletal pain disorder. Am J Molecul Genet 2006;141:449-62.
40. Diatchenko L, Slade GD, Nackley AG, et al. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Med Genet 2005;14:135-43.
41. Vyden J, Groseth-Dittrich M, Callis G, et al. Arthrit Rheumat (abstract) 1971;14.
42. Baerwald CG, Laufenberg M, Specht T, et al. Impaired sympathetic influence on the immune response in patients with rheumatoid arthritis due to lymphocyte subset-specific modulation of beta 2-adrenergic receptors. Br J Rheumatol 1997;36:1262-9.
43. Kaplan R, Robinson CA, Scavulli JF, et al. Propranolol and the treatment of rheumatoid arthritis. Arthritis Rheum 1980;23:253-5.
44. Levine JD, Fye K, Heller P, et al. Clinical response to regional intravenous guanethidine in patients with rheumatoid arthritis. J Rheumatol 1986;13:1040-3.
45. Tchivileva IE, Lim PF, Kasravi P, et al. Propranolol in Temporomandibular Joint Disorder Treatment. San Diego, CA: American Pain Society; 2009.
46. McLean SA, Diatchenko L, Lee YM, et al. Catechol O-methyltransferase haplotype predicts immediate musculoskeletal neck pain and psychological symptoms after motor vehicle collision. J Pain 2011;12:101-7.
47. Carroll LJ, Holm LW, Hogg-Johnson S, et al. Course and prognostic factors for neck pain in whiplash-associated disorders (WAD): results of the Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders. Spine (Phila Pa 1976) 2008; 33: S83-92.
48. Pertovaara A. Noradrenergic pain modulation. Prog Neurobiol 2006;80:53-83.
49. Gonzalez-Cabrera PJ, Gaivin RJ, Yun J, et al. Genetic profiling of alpha 1-adrenergic receptor subtypes by oligonucleotide microarrays: coupling to interleukin-6 secretion but differences in STAT3 phosphorylation and gp-130. Mol Pharmacol 2003;63:1104-16.
50. Hong Y, Abbott FV. Contribution of peripheral alpha 1A-adrenoceptors to pain induced by formalin or by alpha-methyl-5-hydroxytryptamine plus noradrenaline. Eur J Pharmacol 1996;301:41-8.
51. Mailis-Gagnon A, Bennett GJ. Abnormal contralateral pain responses from an intradermal injection of phenylephrine in a subset of patients with complex regional pain syndrome (CRPS). Pain 2004;111:378-84.
52. Ali Z, Ringkamp M, Hartke TV, et al. Uninjured C-fiber nociceptors develop spontaneous activity and alpha-adrenergic sensitivity following L6 spinal nerve ligation in monkey. J Neurophysiol 1999;81:455-66.
53. Pluteanu F, Ristoiu V, Flonta ML, et al. Alpha(1)-adrenoceptormediated depolarization and beta-mediated hyperpolarization in cultured rat dorsal root ganglion neurones. Neurosci Lett 2002;329:277-80.
54. Sagen J, Proudfit HK. Evidence for pain modulation by pre- and postsynaptic noradrenergic receptors in the medulla oblongata. Brain Res 1985;331:285-93.
55. Hedo G, Lopez-Garcia JA. Alpha-1A adrenoceptors modulate potentiation of spinal nociceptive pathways in the rat spinal cord in vitro. Neuropharmacology 2001;41:862-9.
56. Kingery WS, Guo TZ, Davies MF, et al. The alpha(2A) adrenoceptor and the sympathetic postganglionic neuron contribute to the development of neuropathic heat hyperalgesia in mice. Pain 2000;85:345-58.
57. Harasawa I, Honda K, Tanoue A, et al. Responses to noxious stimuli in mice lacking alpha(1d)-adrenergic receptors. Neuroreport 2003;14:1857-60.
58. Xie J, Ho Lee Y, Wang C, et al. Differential expression of alpha1- adrenoceptor subtype mRNAs in the dorsal root ganglion after spinal nerve ligation. Brain Res Mol Brain Res 2001;93:164-72.
59. Smith S, Slade G, Belfer I, et al. ADRA1A Polymorphisms Associated with Multiple Psychological and Nociceptive Phenotypes Predict Vulnerability to an Idiopathic Pain Condition. Washington, DC: American Pain Society; 2007.
60. Crassous PA, Denis C, Paris H, et al. Interest of alpha2-adrenergic agonists and antagonists in clinical practice: background, facts and perspectives. Curr Top Med Chem 2007;7:187-94.
61. Millan MJ, Bervoets K, Rivet JM, et al. Multiple alpha-2 adrenergic receptor subtypes. II. Evidence for a role of rat R alpha-2A adrenergic receptors in the control of nociception, motor behavior and hippocampal synthesis of noradrenaline. J Pharmacol Exp Ther 1994;270:958-72.
62. Graham BA, Hammond DL, Proudfit HK. Differences in the antinociceptive effects of alpha-2 adrenoceptor agonists in two substrains of Sprague-Dawley rats. J Pharmacol Exp Ther 1997;283:511-9.
63. Kim HJ, Camilleri M, Carlson PJ, et al. Association of distinct alpha(2) adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders. Gut 2004;53:829-37.
64. Small KM, McGraw DW, Liggett SB. Pharmacology and physiology of human adrenergic receptor polymorphisms. Annu Rev Pharmacol Toxicol 2003;43:381-411.
65. Vardeny O, Peppard PE, Finn LA, et al. Beta2 adrenergic receptor polymorphisms and nocturnal blood pressure dipping status in the Wisconsin Sleep Cohort Study. J Am Soc Hypertens 2011;5:114-22.
66. Bruehl S, Chung OY. Interactions between the cardiovascular and pain regulatory systems: an updated review of mechanisms and possible alterations in chronic pain. Neurosci Biobehav Rev 2004;28:395-414.
67. Hagen K, Zwart JA, Holmen J, et al. Does hypertension protect against chronic musculoskeletal complaints? The Nord-Trondelag Health Study. Arch Intern Med 2005;165:916-22.
68. Clauw DJ, Belfer I, Max MB, et al. Increased Frequency of the Minor Allele for beta-3 Adrenergic Receptors in Individuals with Fibromyalgia and Related Syndromes. Boston, MA: American College of Rheumatology; 2007.
69. McBeth J, Silman AJ, Gupta A, et al. Moderation of psychosocial risk factors through dysfunction of the hypothalamic-pituitaryadrenal stress axis in the onset of chronic widespread musculoskeletal pain: findings of a population-based prospective cohort study. Arthritis Rheum 2007;56:360-71.
70. Holliday KL, Nicholl BI, Macfarlane GJ, et al. Genetic variation in the hypothalamic-pituitary-adrenal stress axis influences susceptibility to musculoskeletal pain: results from the EPIFUND study. Ann Rheum Dis 2010;69:556-60.
71. Geiss A, Rohleder N, Kirschbaum C, et al. Predicting the failure of disc surgery by a hypofunctional HPA axis: evidence from a prospective study on patients undergoing disc surgery. Pain 2005;114:104-17.
72. Glass JM, Lyden AK, Petzke F, et al. The effect of brief exercise cessation on pain, fatigue, and mood symptom development in healthy, fit individuals. J Psychosom Res 2004;57:391-8.
73. Watkins LR, Maier SF, Goehler LE. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 1995;63:289-302.
74. Biddie SC, Hager GL. Glucocorticoid receptor dynamics and gene regulation. Stress 2009;12:193-205.
75. Myers B, Greenwood-Van Meerveld B. Divergent effects of amygdala glucocorticoid and mineralocorticoid receptors in the regulation of visceral and somatic pain. Am J Physiol Gastrointest Liver Physiol 2010; 298: G295-303.
76. De Nicola AF, Moses DF, Gonzalez S, et al. Adrenocorticoid action in the spinal cord: some unique molecular properties of glucocorticoid receptors. Cell Mol Neurobiol 1989;9:179-92.
77. Cintra A, Molander C, Fuxe K. Colocalization of Fos- and glucocorticoid receptor-immunoreactivities is present only in a very restricted population of dorsal horn neurons of the rat spinal cord after nociceptive stimulation. Brain Res 1993;632:334-8.
78. Capasso A, Di Giannuario A, Loizzo A, et al. Central interaction of dexamethasone and RU-38486 on morphine antinociception in mice. Life Sci 1992; 51: PL139-43.
79. Pieretti S, Capasso A, Di Giannuario A, et al. The interaction of peripherally and centrally administered dexamethasone and RU 38486 on morphine analgesia in mice. Gen Pharmacol 1991;22:929-33.
80. Lim G, Wang S, Zeng Q, et al. Evidence for a long-term influence on morphine tolerance after previous morphine exposure: role of neuronal glucocorticoid receptors. Pain 2005;114:81-92.
81. Capasso A, Loizzo A. Functional interference of dexamethasone on some morphine effects: hypothesis for the steroid-opioid interaction. Recent Pat CNS Drug Discov 2008;3:138-50.
82. van Rossum EF, Lamberts SW. Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition. Recent Prog Horm Res 2004;59:333-57.
83. Wust S, Van Rossum EF, Federenko IS, et al. Common polymorphisms in the glucocorticoid receptor gene are associated with adrenocortical responses to psychosocial stress. J Clin Endocrinol Metab 2004;89:565-73.
84. Filip M, Bader M. Overview on 5-HT receptors and their role in physiology and pathology of the central nervous system. Pharmacol Rep 2009;61:761-77.
85. Millan MJ. Descending control of pain. Prog Neurobiol 2002;66:355-474.
86. Chaouloff F. Serotonin, stress and corticoids. J Psychopharmacol 2000;14:139-51.
87. Hain HS, Belknap JK, Mogil JS. Pharmacogenetic evidence for the involvement of 5-hydroxytryptamine (Serotonin)-1B receptors in the mediation of morphine antinociceptive sensitivity. J Pharmacol Exp Ther 1999;291:444-9.
88. Song B, Chen W, Marvizon JC. Inhibition of opioid release in the rat spinal cord by serotonin 5-HT(1A) receptors. Brain Res 2007;1158:57-62.
89. Buskila D, Neumann L. Genetics of fibromyalgia. Curr Pain Headache Rep 2005;9:313-5.
90. Yeo A, Boyd P, Lumsden S, et al. Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women. Gut 2004;53:1452-8.
91. Park JW, Kim JS, Lee HK, et al. Serotonin transporter polymorphism and harm avoidance personality in chronic tension-type headache. Headache 2004;44:1005-9.
92. Suarez-Roca H, Quintero L, Arcaya JL, et al. Stress-induced muscle and cutaneous hyperalgesia: differential effect of milnacipran. Physiol Behav 2006;88:82-7.